Table 3 Type and frequency of late radiotherapy adverse effects (LENTSOMA) at 1 year

From: A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes

Late toxicity

G0

G1

G2

G3

G4

Skin

88

12

0

0

0

Subcutaneous tissue

84

16

0

0

0

Mucosa

98

2

0

0

0

Pharynx/dysphagia

86

13

1

0

0

Ototoxicity

78

14

7

1

0

Subjective xerostomia

24

55

21

0

0

Objective xerostomia

34

57

9

0

0

Oesophagus

90

8

0

2

0

Larynx

88

10

2

0

0

Spinal cord

100

0

0

0

0

Back to article page